LOGO
LOGO

Entertainment News

Curebound Benefit Concert With P!NK Raises Over $8.25 Million For Cancer Research

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
pink 12022026 lt

Curebound, a cancer research accelerator, has announced that its 2026 Concert for Cures, headlined by global music icon P!NK, raised $8.25 million, bringing the total raised across the four-year history of the concert series to more than $28 million for cancer research.

The May 15 concert at Petco Park drew 25,000 fans, including thousands of cancer survivors, 1,500 who were invited to attend by the Manchester Family Foundation.

P!NK delivered an exhilarating, high-flying performance that brought the Petco Park crowd to its feet from the first note. Known worldwide for her fearless live shows and powerhouse vocals, the global superstar delivered her biggest hits and emotional stripped-down moments, turning the stadium into one of the most memorable nights in Concert for Cures history.

During her performance, P!NK reiterated from the stage, "I want to give a shoutout to Curebound because you are doing some of the most important work that there is to do. Cancer sucks and I am just very grateful to be of use, and I am very grateful to be here with all of you, and I am just very grateful."

Curebound CEO Robin Toft also delivered powerful remarks on stage that connected the energy of the night to the urgency of the mission, underscoring the importance of continuing to support cancer research.

For comments and feedback contact: editorial@rttnews.com

Entertainment News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19